Inhibition of EZH2 through GSK343 treatment resulted in a significant decrease in melanoma cell migration in the A2058-empty MM96L− empty control cells when compared with the vehicle (DMSO) control cells (Figs. 4D, 5E and S6B). The gene discussed is EZH2; the disease is melanoma.